Table 2 Cardiac CT parameter of the study population
Variable | Group I (n = 24) | Group II (n = 17) | Group III (n = 21) | Group IV (n = 14) | Control (n = 32) | P values |
|---|---|---|---|---|---|---|
LVEF (%) | 63.3 ± 9 | 63.6 ± 8 | 63.1 ± 9 | 59 ± 13 | 63.9 ± 7 | 0.586 |
LVEDV (ml) | 90 ± 19 | 84.9 ± 30 | 82.5 ± 19 | 90.1 ± 17 | 87 ± 15 | 0.719 |
LVESV (ml) | 32.8 ± 10 | 40.6 ± 18 | 30.9 ± 11 | 37.3 ± 17 | 32 ± 10 | 0.257 |
CS (%) | ||||||
 LAD territory (%) | −24.1 ± 4 | −25.3 ± 6 | −22.4 ± 4*,a | − 22.1 ± 4*,a,b | − 25.4 ± 4 | 0.062 |
 Non- LAD territory (%) | −25.6 ± 5 | −24.4 ± 4 | − 25.9 ± 4 | − 22.9 ± 5 | −27.4 ± 5 | 0.052 |
 GCS (%) | −25 ± 4 | −24.1 ± 4 | − 24.7 ± 6 | −22.4 ± 4 | −26.6 ± 4 | 0.115 |
RS (%) | ||||||
 LAD territory (%) | 76.6 ± 25 | 79.1 ± 42 | 93.1 ± 56 | 63 ± 23 | 88 ± 38 | 0.186 |
 Non- LAD territory (%) | 90 ± 36 | 96.5 ± 80 | 74.9 ± 23 | 76.4 ± 26 | 84.3 ± 28 | 0.74 |
 GRS (%) | 85.1 ± 26 | 89.1 ± 55 | 81.4 ± 25 | 71.7 ± 23 | 85.3 ± 32 | 0.628 |
LS (%) | ||||||
 LAD territory (%) | −20.8 ± 3 | −18.6 ± 4*,a | −18.6 ± 3*,a,b | −17 ± 5*,a,b,c | −23.7 ± 3 | <0.001 |
 Non- LAD territory (%) | −22.0 ± 3 | −21.9 ± 3 | −21.9 ± 2 | −20 ± 4 | − 22.0 ± 4 | 0.488 |
 GLS (%) | −20.1 ± 2 | −20.3 ± 3* | − 20.5 ± 3*,a | −18.7 ± 4*,a,b,c | −22.9 ± 3 | <0.001 |